| miR-10b functions as a novel tumor suppressor and is partially silenced by DNA hypermethylation in gastric cancer. | gastric, |
| miR-10b Downregulated by DNA Methylation Acts as a Tumor Suppressor in HPV-Positive Cervical Cancer via Targeting Tiam1 | cervical, |
| miR-10b* as a tumor suppressor that might contribute to guarantee genomic stability, deserving further functional confirmation | None |
| Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. | breast, |
| MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. | glioma, |
| miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer. | gastric, |
| Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling. | oral |
| Treatment after the formation of lymph node metastases arrests the metastatic process without a concomitant effect on primary tumor growth raising the possibility of a context-dependent variation in miR-10b breast oncogenesis | breast, |
| Co-inhibition of microRNA-10b and microRNA-21 exerts synergistic inhibition on the proliferation and invasion of human glioma cells. | glioma, |
| miR-10b may function as oncogenes in bladder cancer cells | bladder, |
| Expression of miR-10b was significantly higher in LN-positive NSCLC. Results suggest that miR-10b may act as an oncogene in NSCLC metastasis. | lung, |
| the multi-tyrosine kinase inhibitor linifanib could significantly inhibit miR-10b and reverse its oncogenic function in breast cancer and liver cancer both in vitro and in vivo. | liver,breast, |